Miller E - Search Results

1

Epidemiological determinants of pertussis.

Miller E, Gay NJ. Miller E, et al. Dev Biol Stand. 1997;89:15-23. Dev Biol Stand. 1997. PMID: 9272331 Review.

2

Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens.

Miller E, Ashworth LA, Robinson A, Waight PA, Irons LI. Miller E, et al. Lancet. 1991 Jan 12;337(8733):70-3. doi: 10.1016/0140-6736(91)90735-8. Lancet. 1991. PMID: 1670725 Clinical Trial.

3

Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.

Thomas MG, Ashworth LA, Miller E, Lambert HP. Thomas MG, et al. Among authors: miller e. J Infect Dis. 1989 Nov;160(5):838-45. doi: 10.1093/infdis/160.5.838. J Infect Dis. 1989. PMID: 2572651

4

The current epidemiology of pertussis in the developed world: UK and West Germany.

Miller E, Farrington CP. Miller E, et al. Tokai J Exp Clin Med. 1988;13 Suppl:97-101. Tokai J Exp Clin Med. 1988. PMID: 3273623

5

Selective rubella vaccination programmes: a survey of districts in England and Wales.

Gay NJ, Valambia S, Galasko D, Miller E. Gay NJ, et al. Among authors: miller e. Commun Dis Rep CDR Rev. 1994 Jun 24;4(7):R77-9. Commun Dis Rep CDR Rev. 1994. PMID: 7520802

6

Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?

Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner P, Miller E. Gay NJ, et al. Among authors: miller e. Commun Dis Rep CDR Rev. 1994 Aug 19;4(9):R104-7. Commun Dis Rep CDR Rev. 1994. PMID: 7522807

7

The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign.

Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, Brown D. Ramsay M, et al. Among authors: miller e. Commun Dis Rep CDR Rev. 1994 Nov 11;4(12):R141-6. Commun Dis Rep CDR Rev. 1994. PMID: 7529089

8

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E. Farrington P, et al. Among authors: miller e. Lancet. 1995 Mar 4;345(8949):567-9. doi: 10.1016/s0140-6736(95)90471-9. Lancet. 1995. PMID: 7619183

9

Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.

Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Gay NJ, et al. Among authors: miller e. Epidemiol Infect. 1995 Aug;115(1):139-56. doi: 10.1017/s0950268800058209. Epidemiol Infect. 1995. PMID: 7641827 Free PMC article.

10

Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.

Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Babad HR, et al. Among authors: miller e. Epidemiol Infect. 1995 Apr;114(2):319-44. doi: 10.1017/s0950268800057976. Epidemiol Infect. 1995. PMID: 7705494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,158 results

Search Page

Filters